| Invarianta | Dynamicb | |||||||
---|---|---|---|---|---|---|---|---|---|
 |  | Low-prevalence area | High-prevalence area | ||||||
Presumptive pathway | 3 swabs (Toolkit) | 2 swabs | 1 swab | 3 swabs (Toolkit) | 2 swabs | 1 swab | 3 swabs (Toolkit) | 2 swabs | 1 swab |
Presumptive determination test(s) outcome | |||||||||
 Sensitivity | 99.6 | 97.4 | 83.9 | 100.0 | 100.0 | 81.2 | 100.0 | 100.0 | 81.2 |
 Specificity | 77.1 | 84.1 | 91.7 | 72.4 | 83.2 | 93.4 | 72.4 | 83.5 | 93.3 |
 PPV | - | - | - | 6.6 | 8.3 | 11.8 | 0.9 | 1.1 | 16.0 |
 NPV | - | - | - | 100.0 | 100.0 | 99.8 | 100.0 | 100.0 | 100.0 |
Confirmation test outcome (all confirmation tests, including those prompted by clinical or contract tracing positive results) | |||||||||
 Sensitivity | 96.6 | 96.6 | 96.6 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
 Specificity | 98.6 | 98.6 | 98.6 | 90.8 | 90.0 | 91.0 | 92.9 | 93.2 | 94.7 |
 PPV | - | - | - | 44.7 | 46.7 | 60.0 | 14.1 | 17.4 | 31.2 |
 NPV | - | - | - | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |